Navigation Links
Diabetes treatment may also provide protection against endometrial cancer
Date:4/5/2011

Research led by Warwick Medical School at the University of Warwick has found that Metformin, a drug treatment used to treat diabetes and also in women with Polycystic vary syndrome (PCOS), may potentially provide protection against endometrial cancer.

Endometrial cancer is the most common malignancy of the female genital tract and the fourth most common cancer in women in the UK and the US. Up to a third of PCOS women also have endometrial hyperplasia which, in turn predisposes these women to endometrial cancer. PCOS affects 5%-10% of women of reproductive age, where Metformin ameliorates insulin resistance and hyperinsulinemia in these women, but also long-term use of Metformin improves ovulation and menstrual cycle regularity.

Recent research has found that Metformin has anti-cancer properties e.g. in breast cancer. Given that insulin resistant states, e.g. obesity, diabetes and PCOS are more at risk of developing endometrial cancer, the Warwick researchers studied the effects of metformin treatment on endometrial cancer cells. The researchers used serum from control and PCOS (before and after metformin treatment) subjects and carried out basic scientific experiments on endometrial cancer cells. The experiments revealed a decrease in endometrial cancer cell invasiveness in sera from metformin treated PCOS women.

The researchers found that serum samples from PCOS women who had completed the 6 month course of Metformin the rate of spread of endometrial cancer cells was around 25% lower than in the serum samples from PCOS women who had not started that treatment.

The principal investigators, Dr Harpal Randeva and Dr Bee K Tan, at Warwick Medical School said: "We are very excited about our findings, which reveal the significant impact of Metformin therapy use on human endometrial cancer cells. However, it is prudent that further research to explore if Metformin would actually be beneficial clinically as adjuvant therapy in endometrial cancer; this would need to be addressed through a randomized controlled trial."


'/>"/>

Contact: Dr. Harpal S. Randeva
Harpal.Randeva@warwick.ac.uk
44-247-657-2552
University of Warwick
Source:Eurekalert  

Related medicine news :

1. Add Cancer to Health Risks of Diabetes: Study
2. Avoiding or controlling diabetes may reduce cancer risk and mortality
3. Bariatric surgery reduces long-term cardiovascular risk in diabetes patients
4. Bariatric surgery highly cost-effective treatment for type 2 diabetes in the obese
5. International Diabetes Federation supports surgery to treat diabetes
6. Nick Jonas Lives Large, Despite Diabetes
7. Actos Cut Risk of Prediabetes Becoming Diabetes in Study
8. Study Ties Asthma to Higher Odds for Diabetes, Heart Disease
9. Metabolite levels may be able to improve diabetes risk prediction
10. Analysis Confirms Diabetes Drug May Harm the Heart
11. Diabetes Surgery 2nd World Congress
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Diabetes treatment may also provide protection against endometrial cancer
(Date:2/27/2017)... ... February 27, 2017 , ... Robert E. Burke, MD, PhD, had a ... impoverished upbringing and life experiences could have led him down a much different path. ... Tales of Parenting, Perseverance and Pediatrics,” Dr. Burke shares a personal account of the ...
(Date:2/27/2017)... ... February 27, 2017 , ... Elisa Guajardo Carothers is not your typical author. She ... to become a nun. Now, she writes about God, when she isn’t swimming as a ... and AD, Here is BS! (Before Satan),” she offers a comedic look at the dysfunctions ...
(Date:2/27/2017)... ... February 27, 2017 , ... POUGHKEEPSIE, N. Y. – Peer-reviewed guidelines from ... scientific studies, the Center for Disease Control ( CDC ) and Infectious Diseases Society ... B. Liegner, M.D. has compiled into a single volume a compelling argument that the ...
(Date:2/27/2017)... ... February 27, 2017 , ... Silicon Valley Hair ... to announce an upgrade to the company's Yelp listing. Bay Area residents struggling ... as diverse as Platelet Rich Plasma (PRP) therapy, hair transplantation techniques such as ...
(Date:2/26/2017)... , ... February 26, 2017 , ... ... 2011 the lab became the world’s first to be ISO/IEC 17025:2005 INAB accredited ... allergen) analysis. , ISO/IEC 17025:2005 is the globally recognised standard that sets out ...
Breaking Medicine News(10 mins):
(Date:2/27/2017)... The Netherlands , Feb 27, 2017 ... is approved by NATO for use at the security ... security imposed within the NATO organization for the communication of ... ... providing government authorities with an eavesdrop-secure smartphone solution. Sectra Tiger/R ...
(Date:2/24/2017)... February 24, 2017 Following receiving ... Israel , s AMAR is a major ... 250 M w ound care market in ... BST for inclusion in the National Health Basket ...   E-QURE Corp. (OTCQB: EQUR), a leader ...
(Date:2/24/2017)... 2017 Zimmer Biomet Holdings, Inc. (NYSE and ... present at the Cowen and Company 37 th ... Place on Tuesday, March 7, 2017 at 11:20 a.m. ... the presentation can be accessed at http://wsw.com/webcast/cowen38/zbh .  ... conference via Zimmer Biomet,s Investor Relations website at ...
Breaking Medicine Technology: